Due to their pivotal roles in immune regulation, interleukins are often targeted in clinical settings. Therapeutic agents that mimic or inhibit interleukins are used to treat various conditions. For instance, IL-2 therapy is employed in some cancer treatments, while IL-1 and IL-6 inhibitors are used in the management of autoimmune diseases such as rheumatoid arthritis.
